Pancreatic Cancer Research

ResearcherWashington University in St. LouisNo recent work listed

Melissa A. Meyer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3050-4819; OpenAlex author ID A5007023070. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 2

  1. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance. Co-author DOI 10.1038/s41467-018-03600-6↗
  2. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Co-author DOI 10.1158/0008-5472.can-13-3723↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David C. Linehan · 2 shared papers, 2014–2018 · strength 0.11
  2. Timothy M. Nywening · 2 shared papers, 2014–2018 · strength 0.11
  3. David G DeNardo · 2 shared papers, 2014–2018 · strength 0.11
  4. John M. Baer · 1 shared paper, 2018 · strength 0.07
  5. William G. Hawkins · 1 shared paper, 2018 · strength 0.07
  6. Cynthia X Ma · 1 shared paper, 2018 · strength 0.07
  7. Roheena Z. Panni · 1 shared paper, 2018 · strength 0.07
  8. Ryan C Fields · 1 shared paper, 2018 · strength 0.07
  9. Yu Zhu · 1 shared paper, 2014 · strength 0.04
  10. Andrea Wang‐Gillam · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.